Madison Square Garden Sports Corp. (MSG)
$237.22 0.00 (0.00%)
18:30 EDT MSG Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 4.54B
PE Ratio 54.66
Volume (Avg. Vol.)
Day's Range 237.22 - 237.22
52-Week Range 182.47 - 316.39
Dividend & Yield N/A (N/A)
MSG Stock Predictions, Articles, and Madison Square Garden Sports Corp. News
- From InvestorPlace
- From the Web
Madison Square Garden (MSG) earnings for the venue company's fiscal second quarter of 2020 have MSG stock falling on Friday.
Apple's health initiative can't keep key people and Sarepta Therapeutics' CLR are a couple more top news items about the stock market today.
Want to live your best retirement? These are the 10 baby boomer stocks to buy and hold, based on reliable trends of where boomers are unloading thier money.
Madison Square Garden has ambitious plans to separate its sports and entertainment operations. Here's what investors should expect from MSG stock in the days ahead.
MSG Sphere is an upcoming venue in the Las Vegas strip that's being spearheaded by The Madison Square Garden Company (MSG) and Las Vegas Sands (LVS).
Sports betting is no longer banned at the federal level, opening the door of opportunity for these companies more than any others.
Wilks Brothers increases stake in Carbo Ceramics (CRR), PenderFund reports 5.6% stake in Mattersight (MATR) as part of this week's notable investor filings.
Madison Square Garden Co (MSG) is altering customers to a new data breach that was found last month and lasted for almost a year.
This week, the ratings of 7 Media stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Madison Square Garden (MSG) shares are falling as the company's earnings missed expectations, while its sister company outperformed projections.
Services stocks rose broadly on Wall Street so far on Friday, with the sector seeing an overall increase of 0.1%.
Services stocks finished up 0.4% on Wall Street on Wednesday.
Services stocks declined on Wall Street so far on Thursday, down 0.4%.
Madison Square Garden stock was up on Wednesday following an upgrade from Stifel analysts and a new price target of $190.
Analysts Are Bullish on These Healthcare Stocks: Biohaven Pharmaceutical Holding Co (BHVN), Pfenex (PFNX)
From Analyst Ratings
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biohaven Pharmaceutical Holding Co (BHVN – Research Report), Pfenex (PFNX – Research Report) and Karuna Therapeutics (KRTX – Research Report) with bullish sentiments. Biohaven Pharmaceutical Holding Co (BHVN) In a report issued on June 24, Tim Lugo
From Analyst Ratings
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CRH Medical (CRHM – Research Report), Merus (MRUS – Research Report) and Biohaven Pharmaceutical Holding Co (BHVN – Research Report) with bullish sentiments. CRH Medical (CRHM) Canaccord Genuity analyst Michael Walkley maintained a Buy rating on CRH
From Seeking Alpha